Cite
Xu L, Kim ME, Polski A, et al. Establishing the Clinical Utility of ctDNA Analysis for Diagnosis, Prognosis, and Treatment Monitoring of Retinoblastoma: The Aqueous Humor Liquid Biopsy. Cancers (Basel). 2021;13(6)doi: 10.3390/cancers13061282.
Xu, L., Kim, M. E., Polski, A., Prabakar, R. K., Shen, L., Peng, C. C., Reid, M. W., Chévez-Barrios, P., Kim, J. W., Shah, R., Jubran, R., Kuhn, P., Cobrinik, D., Biegel, J. A., Gai, X., Hicks, J., & Berry, J. L. (2021). Establishing the Clinical Utility of ctDNA Analysis for Diagnosis, Prognosis, and Treatment Monitoring of Retinoblastoma: The Aqueous Humor Liquid Biopsy. Cancers, 13(6), . https://doi.org/10.3390/cancers13061282
Xu, Liya, et al. "Establishing the Clinical Utility of ctDNA Analysis for Diagnosis, Prognosis, and Treatment Monitoring of Retinoblastoma: The Aqueous Humor Liquid Biopsy." Cancers vol. 13,6 (2021). doi: https://doi.org/10.3390/cancers13061282
Xu L, Kim ME, Polski A, Prabakar RK, Shen L, Peng CC, Reid MW, Chévez-Barrios P, Kim JW, Shah R, Jubran R, Kuhn P, Cobrinik D, Biegel JA, Gai X, Hicks J, Berry JL. Establishing the Clinical Utility of ctDNA Analysis for Diagnosis, Prognosis, and Treatment Monitoring of Retinoblastoma: The Aqueous Humor Liquid Biopsy. Cancers (Basel). 2021 Mar 13;13(6). doi: 10.3390/cancers13061282. PMID: 33805776; PMCID: PMC8001323.
Copy
Download .nbib